logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jonathan E. Rosenberg

Memorial Sloan Kettering Cancer Center
H指数:85
被引数:5.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

78 Dietary Fructose Intake and Tumoral Fructose-Metabolism Gene Expression in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

78 饮食果糖摄入与接受免疫检查点阻断治疗转移性肾细胞癌的肿瘤果糖代谢基因表达

Oncologist
IF4.2
2026-09-020
OAAI
Antonio Ocejo; Stanley Liang; Carlene Gonzalez; Allen Mena; Nicholina Metzer; Cihan Duzgol; Jeeban P Das; Ashley Regazzi; Bradley Reinfeld; Sahil D Doshi; Phillip Rappold; Maria I Carlo; Darren R Feldman; Neil J Shah; Jonathan E Rosenberg; Robert J Motzer; Gopa Iyer; Martin H Voss; Ritesh R Kotecha; Brendan J Guercio
Platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in metastatic urothelial carcinoma: a real-world study☆

恩康坦（enfortumab vedotin）和帕博利珠单抗（pembrolizumab）治疗转移性尿路上皮癌后铂类化疗：一项真实世界研究☆

ESMO Open
IF8.3
2026-07-240
OAAI
M. Sternschuss; K. Whiting; A. Arbuiso; A. Gupta; E. Bent; N. Alvarez; A. Regazzi; S. Liang; F. Ahmed; O. Akin; V. Beylergil; S. Niglio; D. Lage; S.A. Funt; D. Bajorin; G. Iyer; D. Aggen; I. Ostrovnaya; J.E. Rosenberg
EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma

EV-103剂量递增/队列A：恩沃利单抗 vedotin 联合帕博利珠单抗治疗既往未治疗的局部晚期/转移性尿路上皮癌的5年随访

ESMO Open
IF8.3
2026-05-190
OAAI
J.E. Rosenberg; P.H. O'Donnell; D.P. Petrylak; T.W. Flaig; C.J. Hoimes; S. Gupta; N. Mar; T.W. Friedlander; S.T. Tagawa; M.A. Bilen; J.R. Brown; R.R. McKay; J.R. Merchan; S. Srinivas; S. Gorla; B.H. Moreno; G. Davis; H.S. Wirtz; Y. Zhu; M.I. Milowsky
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

临床结局、基因组异质性及不同组织学亚型的尿路上皮癌的治疗考量

European Urology
IF25.2
2025-04-260
PRE
Carissa E. Chu; Ziyu Chen; Karissa Whiting; Irina Ostrovnaya; Andrew T. Lenis; Timothy N. Clinton; Rayan Rammal; Gamze Gokturk Ozcan; Dilara Akbulut; Merve Basar; Jie-Fu Chen; Ying-Bei Chen; Anuradha Gopalan; Samson W. Fine; Satish K. Tickoo; Maria Arcila; A. Rose Brannon; Michael F. Berger; Eugene K. Cha; Alvin C. Goh; Timothy F. Donahue; Dean F. Bajorin; Min Yuen Teo; Jonathan E. Rosenberg; Gopa Iyer; Eugene J. Pietzak; Bernard H. Bochner; Victor E. Reuter; Judy Sarungbam; David B. Solit; Hikmat Al-Ahmadie
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group

Gupta, S.; Hensley, P.J.; Li, R.; Choudhury, A.; Daneshmand, S.; Faltas, B.M.; Flaig, T.W.; Grass, G.D.; Grivas, P.; Hansel, D.E. 肌层浸润性膀胱癌的保膀胱策略：国际膀胱癌小组的建议。Eur. Urol. 2025, 已接受待发表。 [Google Scholar] [CrossRef]

European Urology
IF25.2
2025-04-220
PRE
Shilpa Gupta; Patrick J. Hensley; Roger Li; Ananya Choudhury; Siamak Daneshmand; Bishoy M. Faltas; Thomas W. Flaig; G. Daniel Grass; Petros Grivas; Donna E. Hansel; Comron Hassanzadeh; Wassim Kassouf; Janet Kukreja; Arturo Mendoza-Valdés; Marco Moschini; Kent W. Mouw; Neema Navai; Andrea Necchi; Jonathan E. Rosenberg; Jeffrey S. Ross
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

分子异质性和免疫浸润驱动上尿路尿路上皮癌的临床结局

EUROPEAN UROLOGY
IF25.2
2025-03-011
OAAI
Kim, Kwanghee; Alam, Syed M.; Kuo, Fengshen; Chen, Ziyu; Yip, Wesley; Katims, Andrew B.; Chu, Carissa; Lenis, Andrew T.; Hu, Wenhuo; Ozcan, Gamze Gokturk; Chen, Jie-Fu; Firouzi, Sanaz; Elhanati, Yuval; Clinton, Timothy N.; Aulitzky, Andreas; Almassi, Nima; Fujii, Yoich; Tracey, Andrew T.; Reisz, Peter A.; Budhu, Sadna; Vuong, Lynda; Eichholz, Jordan; Woo, Hyung Jun; Nogueira, Lucas; Gao, Sizhi P.; Scherz, Avigdor; Aggen, David H.; Rosenberg, Jonathan E.; Pietzak, Eugene J.; Seshan, Venkatraman; Greenbaum, Benjamin; Becker, Anton; Akin, Oguz; Iyer, Gopa; Al-Ahmadie, Hikmat; Hakimi, A. Ari; Merghoub, Taha; Coleman, Jonathan A.
Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution

联盟A031501：AMBASSADOR研究，评估辅助治疗中帕博利珠单抗（Pembro）在肌肉浸润性尿路上皮癌（MIUC）与观察（Obs）相比的扩展随访无病生存期（DFS）结果及转移性（met）疾病复发的分布

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Apolo, A. B.; Ballman, K.; Sonpavde, G. P.; Berg, S.; Kim, W.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D.; Grivas, P.; Chatta, G.; Reichert, Z.; Kim, J. W.; Bilen, M. A.; McGregor, B. A.; Srinivas, S.; Halabi, S.; Burbano, G. Perez; Morris, M. J.; Rosenberg, J. E.
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

EV-301既往接受过治疗的晚期尿路上皮癌患者的健康相关生活质量: Enfortumab Vedotin与化疗的3期试验

EUROPEAN UROLOGY
IF25.2
2024-06-014
OAAI
Rosenberg, Jonathan E.; Mamtani, Ronac; Sonpavde, Guru P.; Loriot, Yohann; Duran, Ignacio; Lee, Jae-Lyun; Matsubara, Nobuaki; Vulsteke, Christof; Castellano, Daniel; Sridhar, Srikala S.; Pappot, Helle; Gurney, Howard; Bedke, Jens; van der Heijden, Michiel S.; Galli, Luca; Keam, Bhumsuk; Masumori, Naoya; Meran, Johannes; O'Donnell, Peter H.; Park, Se Hoon; Grande, Enrique; Sengelov, Lisa; Uemura, Hiroji; Skaltsa, Konstantina; Campbell, Mary; Matsangou, Maria; Wu, Chunzhang; Hepp, Zsolt; Mckay, Caroline; Powles, Thomas; Petrylak, Daniel P.
PHASE I STUDY OF INTRAVESICAL FC-OPTIMIZED ANTI-CD40 AGONIST ANTIBODY 2141-V11 FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
JOURNAL OF UROLOGY
IF6.8
2024-05-010
PRE
Bochner, Bernard H.; Alam, Muneeb; Osorio, Juan C.; Wong, Jeffrey L.; Knorr, David; Blanchard, Lucas; Angulo-Lozano, Juan; Whiting, Karissa; Seshan, Venkatraman E.; Donahue, Timothy; Cha, Eugene; Goh, Alvin; Smith, Robert; Dalbagni, Guido; Hernandez, Christian; McCarter, Melissa; Pietzak, Eugene J.; Rosenberg, Jonathan E.; Ravetch, Jeffrey V.
Phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) therapy
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Osorio, Juan C.; Alam, Muneeb; Wong, Jeffrey; Knorr, David; Blanchard, Lucas; Angulo-Lozano, Juan C.; Whiting, Karissa; Seshan, Venkatraman E.; Donahue, Timothy F.; Cha, Eugene K.; Goh, Alvin C.; Smith, Robert; Dalbagni, Guido; Hernandez, Christian; McCarter, Melissa; Pietzak, Eugene J.; Rosenberg, Jonathan E.; Ravetch, Jeffrey V.; Bochner, Bernard H.
A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Rosenberg, Jonathan; Sabatier, Renaud; Viceneux, Armelle; Rouge, Thibault De la Motte; Champiat, Stephane; Lebellec, Loic; Barthelemy, Philippe; Sonpavde, Guru; Gao, Xin; Niglio, Scot; Zhang, Tian; Gedye, Craig; Galsky, Matthew; Milowsky, Matthew; Reimers, Melissa; Weickhardt, Andrew; Grande, Enrique; Castellano, Daniel E.; Bilen, Mehmet; Patnaik, Amita; Zerbib, Robert; Balbas, Minna; Xu, Xiaojian; Aptaker, Kaitlyn; Balar, Arjun V.; Awada, Ahmad H.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab

探索未经治疗的局部晚期或转移性尿路上皮癌的新治疗组合: enfortumab vedotin加pembrolizumab

FUTURE ONCOLOGY
IF2.6
2023-11-230
OAAI
Hoimes, Christopher J.; Flaig, Thomas W.; Milowsky, Matthew, I; Friedlander, Terence W.; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R.; Mckay, Rana R.; Petrylak, Daniel P.; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E.

研究方向

暂未获取到该数据
D
Dean F. Bajorin
H 指数:98论文数:866被引数:4.8万
H
Hikmat Al‐Ahmadie
H 指数:106论文数:809被引数:8.7万
B
Bernard H. Bochner
H 指数:82论文数:766被引数:4.0万
D
David B. Solit
H 指数:139论文数:1,839被引数:8.4万
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万
G
Gopa Iyer
H 指数:55论文数:517被引数:2.4万
M
Michael F. Berger
H 指数:131论文数:1,361被引数:8.9万
G
Guido Dalbagni
H 指数:77论文数:706被引数:2.3万
A
Andrea Necchi
H 指数:70论文数:1,307被引数:3.2万
M
Matthew D. Galsky
H 指数:79论文数:852被引数:3.4万